The widespread Tylenol lawsuits over the drug’s role in child Autism and ADHD development have now become concentrated in multi-district litigation with leadership roles for involved product liability lawyers now open. Tylenol and other drugs containing acetaminophen have been linked to an increased risk of autism, ADHD, and other developmental disorders as a result of mothers taking these drugs while pregnant.
If you have a child that suffers from a developmental disorder like autism or ADHD attributed to maternal Tylenol use during pregnancy then consider contacting Dolman Law Group about filing a product liability lawsuit against those responsible for the damages you and your child have suffered. Our firm offers free consultations to those harmed by this controversy involving Tylenol and can inform you of your rights regarding this matter and how our Tylenol autism lawyers can help you.
Tylenol Lawsuit Multidistrict Litigation and Proposed Plaintiff Attorneys Leadership Structure
Tylenol has come under fire due to its alleged role in the development of Autism and ADHD among children whose mothers took the drug while pregnant. The resulting legal fallout has seen a multitude of product liability lawsuits filed with retailers like Walmart, CVS, Walgreens, etc paying the price and now Tylenol’s maker, Johnson and Johnson, is posed to face consequences as well.
Due to the scale of these Tylenol autism lawsuits, the need for multidistrict litigation (MDL) was established to consolidate the various complaints against Tylenol distributors and makers. Senior U.S. District Judge Denise Cote in the Southern District of New York was appointed to preside over the various Federal Tylenol lawsuits and is overseeing the MDL intended to coordinate the various cases in terms of discovery into common issues among the lawsuits and ready a set of bellwether cases for future trials.
What is Multidistrict Litigation?
There are many lawsuits that involve circumstances that are applicable to a large number of potential plaintiffs across multiple states. In cases such as this, there can be a need to group all of these similar cases before a single Federal judge in order to forego the chaos and time consumption generated by each individual case being tried independently.
This consolidation of lawsuits is known as multidistrict litigation (MDL) and involves the consolidated cases all working together through the pretrial process of discovery and in many cases the trying of a set of bellwether cases. These bellwether trials function as a set of trials intended to be representative of the various cases consolidated under an MDL in order for both plaintiffs and defendants to gauge the strength of their respective cases in court. Depending on how these bellwether trials go, plaintiffs can expect to see some kind of global settlement for all of the MDL cases or a need to reassess legal approach.
MDLs by nature also necessitate the appointing of certain lawyers in leadership positions to manage the many aspects of these consolidated cases. These lawyers are responsible for making decisions on the behalf of the many individual plaintiffs that are part of the multidistrict litigation.
The Roles and Organization of the Plaintiffs’ Attorney Leadership Structure
Last week, Judge Cote issued a court order (PDF) that clarified the plaintiff’s attorney leadership structure that will be utilized by the Tylenol autism multidistrict litigation. The court order dictates that there will be specific attorneys appointed to serve as lead counsel and liaison counsel along with two more groups that will be appointed to a plaintiff’s executive committee and a plaintiff’s steering committee. The lawyers that will be appointed to the aforementioned leadership positions will form at least five sub-committees that will include the following:
- Early Vetting/Bellwether Selection Committee
- Science and Experts Committee
- Discovery/ESI Committee
- Law & Briefing Committee
- Settlement/Lien Resolution Committee
There is currently an open application process in place to determine the appointment of Tylenol lawsuit lawyers to these leadership positions including lead counsel, liaison counsel, the chair of a sub-committee, or for membership in the plaintiffs’ steering committee. The deadline for these applications will be November 16th at noon. The selections for these leadership roles will be announced on November 17th at an initial status conference for the litigation.
In addition to the court order issued regarding the MDL plaintiff leadership structure, Judge Cote also issued another court order (PDF) the next day approving the defendants in the Tylenol lawsuit’s proposed leadership structure. This structure will only consist of a retailer liaison committee and no deadline was provided
Tylenol and its Connection to Increased Child Autism Risk
The Tylenol lawsuits in question allege that Tylenol, also known as acetaminophen or paracetamol, exposure in the womb is responsible for developmental issues in children such as the following:
- Autism spectrum disorder (ASD)
- ADHD (Attention Deficit Hyperactivity Disorder)
- Neurodevelopmental problems later in life
- IQ level deficits
- Behavioral issues
- Sleep problems
- Early puberty in girls
- Male fertility problems
- Undescended testicles
These allegations come after a damning 2021 consensus statement authored by several medical experts in Nature Reviews Endocrinology revealed that there is a real risk of fetal development being altered by APAP (acetaminophen) and consequently developmental disorders like autism.
The aforementioned health issues that Tylenol prenatal exposure can increase the risk of can be debilitating and lead to lifelong struggle financially, socially, emotionally, etc. This is why many who have taken the over-the-counter drug, Tylenol, are now outraged. Consumers were not informed of this risk and as a result, people are suffering and now filing product liability lawsuits.
For a free legal consultation, call 833-552-7274
Why Choose Dolman Law Group Defective Drug Attorneys?
Dolman Law Group is a personal injury law firm dedicated to assisting those harmed by defective medications and other pharmaceutical products whether they be prescription or over-the-counter. Product liability lawsuits against the makers of dangerous drugs by default put plaintiffs at a disadvantage.
Pharmaceutical companies have the financial means to wage a legal battle of attrition and keep experienced legal teams on standby to launch a thorough defense. With lawsuits like these, your financial, medical, and even emotional well-being can be on the line which is why you should not hesitate to contact the best legal professionals possible to level the playing field.
Dolman Law Group can be the ally that stands with you through your Tylenol lawsuit and assists you with seeking the maximum value of compensation you and your child deserve for the damages you’ve suffered. Our award-winning lawyers can provide you with legal insight honed after years of successful litigation as well as a myriad of other forms of assistance ranging from representing you in court to assisting you with getting the appropriate paperwork filed on time.
Contact Dolman Law Group for Help With Your Tylenol Autism Lawsuit
If you believe that your child’s autism spectrum disorder, ADHD, or other developmental issues were caused by Tylenol exposed to your child in utero, then contact Dolman Law Group about your potential Tylenol lawsuit case. Getting in contact with our Tylenol autism lawyers is the first step to getting you on track to receiving compensation that can cover damages such as medical bills, lost wages, and even pain and suffering.
Dolman Law Group offers free no obligation consultations to prospective clients. At the very least, meeting with an attorney can provide you with clarity regarding your case’s potential and perhaps some legal options you were not aware of.